rs1553619424
Variant summary
Our verdict is Pathogenic. Variant got 22 ACMG points: 22P and 0B. PS1PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000551.4(VHL):c.240T>A(p.Ser80Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S80N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000551.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 22 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VHL | NM_000551.4 | c.240T>A | p.Ser80Arg | missense_variant | 1/3 | ENST00000256474.3 | NP_000542.1 | |
VHL | NM_001354723.2 | c.240T>A | p.Ser80Arg | missense_variant | 1/3 | NP_001341652.1 | ||
VHL | NM_198156.3 | c.240T>A | p.Ser80Arg | missense_variant | 1/2 | NP_937799.1 | ||
VHL | NR_176335.1 | n.310T>A | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VHL | ENST00000256474.3 | c.240T>A | p.Ser80Arg | missense_variant | 1/3 | 1 | NM_000551.4 | ENSP00000256474.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Von Hippel-Lindau syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Jan 24, 2024 | This variant is considered likely pathogenic. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 19755989, 12624160, 33720516, 12202531, 20978319, 8956040, 29748190]. This variant is expected to disrupt protein structure [Myriad internal data]. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 31, 2023 | The p.S80R variant (also known as c.240T>A), located in coding exon 1 of the VHL gene, results from a T to A substitution at nucleotide position 240. The serine at codon 80 is replaced by arginine, an amino acid with dissimilar properties. Other alterations at the same codon, including p.S80R (c.240T>G) and p.S80G (c.238A>G), have been described in multiple individual with a personal and/or family history that is consistent with VHL-related disease (Crossey PA et al. Hum Mol Genet, 1994 Aug;3:1303-8; Woodward ER et al. Hum Mol Genet. 1997 Jul;6(7):1051-6; Assadi F & Brackbill EL. Am J Kidney Dis. 2003 Jan;41(1):E3; Erlic Z et al. Endocr Relat Cancer, 2010 Dec;17:875-83; Krauss T et al. Endocr Relat Cancer, 2018 Sep;25:783-793). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.